Investments
Investments
What Do We Do
Impact Propelling a Healthier World
We play an actual impact role in healthspan innovation by embracing venture capital's core purpose: de-risking breakthrough ideas. We invest early, even at the idea or company creation stage, taking on more scientific and biological risks. By supporting research from the early steps to the commercialization phase, we pave the way for biotech investors to enter the healthspan space, positioning ourselves as intellectual leaders in healthspan investing.
Building a global ecosystem for change
Adding just one year of healthy lifespan translates into trillions of dollars in increased productivity and GDP. Achieving this vision requires collaboration and bringing together academicians, investigators, entrepreneurs, the biopharmaceutical industry, healthcare providers, policymakers, and regulators to translate discoveries into real-world, safe, and effective solutions.
An inclusive Approach
As a mission-driven organization, we take a pragmatic and inclusive approach, operating internationally without being bound to specific markets or purely philanthropic returns. We aim to extend healthspan for everyone in a way such that there is more equity and accessibility to therapies that help people live healthier, longer. At every step, we are guided by the highest standards of scientific integrity and ethics, ensuring that progress benefits humanity equitably and responsibly.
Driving Impact Through Early Innovation
At Hevolution, we are driving the transition from today’s reactive “sick care” model to proactive healthcare through research and development that meets the highest international standards of science, ethics, and integrity. By increasing the breadth of knowledge in aging biology and translating discoveries into safe and effective solutions, we support existing companies and incubate new ones globally to create novel therapies.
A unique pragmatic and collaborative framework
We work closely with our world-class internal science and grantmaking teams to define broad scientific and investment strategies. Every investment is deeply diligent towards both its scientific rigor and commercial potential. As active venture investors, we collaborate alongside industry leaders, company founders, and other ecosystem players to ensure that real solutions with measurable impact are developed for patients and all stakeholders involved.
Long-term, impact investment with a focus on aging biology
Our focus is on early-stage, programmatic investments in biotech companies that address the mechanisms of aging biology rather than specific diseases. However, we recognize the importance of treating high unmet medical needs today as a pathway to understanding aging at its core. Additionally, through our Breakthrough Innovation Alliance (BIA), we incubate companies with transformational ideas, ensuring they have the expertise, funding, and support to advance from ideation to commercialization.
Our Portfolio
Breakthrough Innovation
Alliance (BIA Venture)
Turning ideas into market-ready innovations
The Breakthrough Innovation Alliance (BIA) is our hands-on initiative to create and support companies advancing healthy aging. Unlike traditional accelerators, we combine capital with practical mentorship and specialized expertise from our network of biopharma leaders, VC investors, academics, and entrepreneurs. We are convening and shepherding a unique consortium of entrepreneurs in residence at Hevolution, VC investors, specialized CROs, and pharma decision-makers to ideate, evaluate, and support the best ideas in healthspan today and tomorrow.
Asking the hard questions early
Success starts with focus. Before committing to creating a new company, we ask and answer the tough questions, ensuring that only the most substantial ideas with truly breakthrough potential move forward. We take an open-minded and broad-range approach to translating big ideas into pragmatic programs by working with entrepreneurs to fund litmus test type catalyst experiments enabling us to establish proof-of-concept data that will both get great companies started and attract Seed through Series B funding from investors.
A more efficient way to build
Our approach increases the chances of success while eliminating wasted effort. When a company is founded, it starts with the right expertise, resources, and strategy in place, ensuring ideas with transformational potential are given the opportunity to thrive.
Type of Projects
Focused toward measurable outcomes- A “BIA project” must meet these criteria:
- A big idea with transformational potential in discovery, data insights, or therapeutics.
- A clear healthspan focus with measurable impact.
- A definable question that can be tested and answered within 12-18 months through targeted funding.
Our Global Impact
How to Get Involved
We always seek bold ideas and visionary partners to join our mission. Reach out to us through your preferred channel today, and we will get back to you as soon as possible.
King Abdullah
Financial District,Riyadh
Saudi Arabia
200 Clarendon
St Boston, MA,
United States